- Home
- AFYA vs RAPT Comparison
AFYA vs RAPT Comparison
Compare AFYA & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AFYA | RAPT |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | Brazil | United States |
| Employees | N/A | 60 |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AFYA | RAPT |
|---|---|---|
| Price | $13.42 | $58.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 10 |
| Target Price | $17.00 | ★ $56.22 |
| AVG Volume (30 Days) | 90.3K | ★ 4.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.67 | N/A |
| Revenue Next Year | $7.84 | N/A |
| P/E Ratio | $9.30 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.12 | $0.71 |
| 52 Week High | $19.76 | $57.99 |
Technical Indicators
Market Signals| Indicator | AFYA | RAPT |
|---|---|---|
| Relative Strength Index (RSI) | 31.69 | 78.59 |
| Support Level | N/A | $32.00 |
| Resistance Level | $15.35 | N/A |
| Average True Range (ATR) | 0.40 | 0.09 |
| MACD | -0.12 | -0.79 |
| Stochastic Oscillator | 10.95 | 95.31 |
Price Performance
Historical ComparisonAbout AFYA Afya Limited
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.